Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Valeant Pharmaceuticals International (VRX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Valeant Pharmaceuticals International. Table 2 shows the detailed insider transactions. This company's CIK number is 930184.
Total stock buying since 2010: $0.
Total stock sales since 2010: $1,040,565.
Total stock option exercises since 2010: $521,640.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 0 | $0 | 23,000 | $1,040,565 | 23,000 | $521,640 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-06 | 0 | $0 | 23,000 | $1,040,565 | 23,000 | $521,640 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-06-09 | De Silva Rajiv (Chief Operating Officer) | Sale | 23,000 | 45.24 | 1,040,565 |
| 2010-06-09 | De Silva Rajiv (Chief Operating Officer) | Option Ex | 23,000 | 22.68 | 521,640 |
Insider trading activities including stock purchases, stock sales, and option exercises of VRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Valeant Pharmaceuticals International (symbol VRX, CIK number 930184) see the Securities and Exchange Commission (SEC) website.